There are three main conclusions in the present study: (1) circulating ALDH1+ cells could be used as a prognostic marker for NSCLC; (2) ALDH1+ cells were associated with tumor differentiation and lymphatic invasion; (3) negative relationship between sTRAIL and ALDH1+ cells. Here, ALDH1A1 is linked to neoplasm.